Okairos has an industry-leading management team and board of directors. Our mix of commercial expertise, scientific talent and academic authority has enabled us to be at the forefront of the development of T-cell based vaccines.
Our respected Chief Executive Officer Riccardo Cortese leads a management team with decades of experience in the pharmaceutical and biotechnology industries.
Our board of directors, led by Chairman Bill Burns, previously Chief Executive Officer of Roche’s Pharmaceuticals Division, also includes Jean-Paul Prieels, former head of research at GSK Vaccines.
Our scientific advisory board brings expertise in immunology and the clinical management of infectious diseases.